Inter Pharma PCL (BKK:IP)

Market Cap	2.11B
Revenue (ttm)	2.05B
Net Income (ttm)	72.22M
Shares Out	605.34M
EPS (ttm)	0.12
PE Ratio	29.17
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,058,470
Average Volume	452,054
Open	3.600
Previous Close	3.460
Day's Range	3.480 - 3.620
52-Week Range	2.020 - 5.150
Beta	0.49
RSI	63.24
Earnings Date	Aug 8, 2025

About Inter Pharma PCL

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IP

Financial Performance

In 2024, Inter Pharma PCL's revenue was 1.91 billion, an increase of 6.29% compared to the previous year's 1.80 billion. Earnings were 37.28 million, a decrease of -26.60%.